Coronavirus: Vaccination

(asked on 5th December 2023) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of allowing people that are not currently eligible for covid-19 booster vaccines to (a) purchase them at an affordable price and (b) receive them free of charge if they are eligible for free prescriptions on levels of people returning to work.


Answered by
Maria Caulfield Portrait
Maria Caulfield
Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
This question was answered on 27th December 2023

The Joint Committee on Vaccination and Immunisation (JCVI), a body of independent experts, advises the Government on who should be offered vaccination through the national programme for COVID-19. Vaccination for COVID-19 through the National Health Service is free for those eligible and there are no plans to introduce charges.

Current COVID-19 vaccines offer good protection against serious outcomes but only short-lived protection from mild symptomatic disease. The aim therefore is to offer vaccination to those the JCVI advises are at higher risk of hospitalisation and death. This risk is strongly linked to older age and some specified clinical conditions.

No recent general assessment has been carried out on the impact of COVID-19 vaccination on absences from work. However, a cost effectiveness assessment has been carried for the groups recommended by the JCVI for autumn 2023 vaccination which includes front line healthcare workers. The analysis for this group explored the potential impact on staff absences due to COVID-19. The available data was insufficient to allow formal conclusions but what data was available suggested that, due to the limited ability of current vaccines to prevent mild illness, vaccination would have only a very modest impact on staff absences. The analysis is published at the following link:

https://assets.publishing.service.gov.uk/media/650ade0f52e73c001254dc08/covid-19-autumn-2023-impact-assessment.pdf

On the advice of the JCVI, NHS eligibility is focussed on those at higher risk of serious outcomes. However, all vaccines that have been licensed by the Medicines and Healthcare products Regulatory Agency for use in the United Kingdom may be prescribed by physicians privately as well as through the NHS. Currently COVID-19 vaccines are not available privately but as is the case for many other vaccines, manufacturers and providers are able to set up a private market alongside the NHS offer when they consider this viable and appropriate. The Government is supportive of the emergence of a private market for COVID-19 vaccines and is engaging with relevant parties on this.

Reticulating Splines